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A commentary on “Risk Factors for Renal cell cancer in a 
Japanese population”
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Abstract: The well-written and researched article reported in Clinical Medicine: Oncology by Dr. Washio and Dr. Mori entitled “Risk 
factors for renal cell cancer in a Japanese population”1 makes evident the differences in incidence and mortality rates from renal cell 
carcinoma (RCC) between different populations and highlights the relevance of carrying out epidemiological studies, investigating 
additional risk factors which may explain the differences.
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The incidence of RCC, which is the most common 
type of kidney cancer, has been increasing worldwide, 
mainly in western countries, in the last three decades 
at a rate between 2% and 4% per year.2–4 Accumulating 
evidence has confirmed this data.
In the world 208,000 new cases are diagnosed and 
102,000 die from this disease each year. More than 
one half have been diagnosed in the United States.3
This incidence rate of RCC varies internationally 
more than 10 fold, with the rates of RCC in Asian 
countries being lower than those of countries in North 
America or Europe.3 This fact suggests a strong role 
for exogenous risk factors, in addition to possible roles of 
geographic differences in genetic susceptibility and 
diagnostic variability.
However, which factors that have influenced this 
increase have not been easy to determine.
On the one hand, the relatively recent improvements 
in diagnostic techniques and the extensive use of the 
computed  tomography  for  studying  other  diseases, 
may have contributed to this rising incidence with 
improved earlier diagnosis. Most tumors diagnosed 
in this way are asymptomatic and therefore incidental 
findings. These findings are supported by the study 
published by Bretheau et al5 which confirms that the 
incidence of these asymptomatic RCC have increased 
from 14% in eighties to 48% in nineties.
However  on  the  other  hand,  I  would  like  to 
highlight  that  both  incidence  of  late  stage  RCC 
detected by symptoms and mortality secondary to it, 
have also been increasing, implying that risk factors 
are  playing  an  important  roll  in  this  upward  trend 
as well.6
Therefore  at  this  point  we  must  ask  ourselves 
who’s at risk, and why?
There  are  many  epidemiological  studies  carried 
out  in  different  countries  around  the  world  that 
seek answers to this question. Although an essential 
precondition  for  any  epidemiological  study  is  to 
identify the relevant physical factors or environmental 
agents  involved  in  a  determined  disease,  our  lack 
of basic knowledge does not allow us to design an 
epidemiological study which is powerful enough to 
resolve a small risk,7 even if such a risk truly exists. 
This is the reason why different studies have identified 
multiple risk factors for RCC, many of them with a 
weak causative association, so the question remains 
unanswered.
Although  multiple  high-risk  groups  for  RCC 
have  been  truly  identified  (obesity,  smoking  and 
hypertension),  with  a  marked  consistency,  taken 
together, these risk factors account only for 49% of 
cases, so a large portion of  RCC still has an unknown 
and unexplained etiology.6 This fact implies that the 
search for additional risk factors must continue. In this 
context observational epidemiological studies remain 
a very important way of  identifying causal associations 
between risk factors and disease. These studies should 
reliably identify powerful causal associations.8–10
Although we know there is racial disparity and 
geographical  differences  in  this  disease,  we  have 
to  obtain  almost  all  this  data  predominantly  from 
non-Asian  patients  (Caucasian  in  Europe,  and 
Caucasian  and  African  American  in  the  United 
States).  This  is  not  the  ideal  as  the  incidence  of 
RCC is higher in Japanese Americans than in native 
Japanese suggesting an implication of environmental 
factors such as life-style as Dr. Washio and Dr. Mori 
highlight in their article.
Conversely  RCC  incidence  has  been  increasing 
in this population too. Thus I consider as they have 
done, that it is very relevant to study risk factors for 
RCC  between  native  Japanese  which  clearly  will 
become important to obtain strong conclusions and to 
prevent it. As Dr. Washio and Dr. Mori have suggested, 
I too consider it is valuable to study, among other 
factors, the implications of a Japanese diet against 
a western diet, although I am aware of this is not 
easy because the difficulties of obtaining meaningful 
dietary  histories  in  a  homogeneous  population  in 
which the social environment could also play a roll.
Since this malignancy is rare, all epidemiological 
studies have a common limitation related to small 
numbers  of  cases  in  certain  risk  factor  categories. 
Because  of  this  it  is  difficult  to  reach  statistical 
significance,7  so  reporting  an  association  between 
a factor and a disease concluding causation is not 
always possible. Environmental epidemiology is very 
difficult to do. Although many risks and associations 
have turned up in the laboratory, they are not well-
established  in  human  epidemiological  studies. The 
risk factors most widely recognized by the scientific 
community are limited to obesity, hypertension and 
smoking.
Establishing this link is not as easy as I first thought. 
Although obesity is a well established risk factor for risk factors for renal cell cancer in a japanese population
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RCC in Western countries11 with a relative risk of 
3.3 (95% confidence interval 1.2–8.7) in women and 
2.3 (95% confidence interval 1.2–4.5) in men. In this 
study obesity shows a meaningful association with 
RCC but a marginal association with RCC death when 
the researchers excluded those cases with a medical 
history of diabetes mellitus (after adjustment for age 
and sex, relative risk was 1.69 with confidence interval 
between  0.87–3.30).  The  increasing  prevalence  of 
obesity may partly explain the increasing incidence 
of RCC. In fact, the proportion of RCC attributable 
to overweight and obesity is estimated to be more 
than 40% in the United States and more than 30% 
in Europe. I would also like to point out that in the 
study by Bretheau et al5 they observed that the rate 
of incidental RCC was higher in groups of patients 
who underwent computed tomography for studying 
cardiovascular diseases or biliary diseases, and they 
concluded that the prognosis was better in these groups 
on finding these incidental tumors, therefore the rate 
of death secondary to RCC was lower. We know that 
this group of diseases is related among other factors 
with obesity, so this fact could have some implication 
in these results, therefore making the interpretation of 
epidemiological data more difficult.
Diabetes  mellitus  has  been  associated  with  an 
increased  risk  in  several  cancers,  however  its 
relationship as an increased risk in regard to RCC 
is  controversial  and  indicates  a  moderate,  if  any, 
increased risk. Only scanty information is available 
on the RCC risk in patients with diabetes. In the study 
by Zuchetto et al12 in an Italian population, when they 
compared patients with and without diabetes, those 
with a diagnosis of diabetes mellitus had a relative 
risk  of  1.25  (95%  confidence  interval  0.91–1.73). 
The  risks  of  RCC  in  relation  with  diabetes  were 
similar across the strata of sex, body mass index and 
smoking.
Dr.  Washio  and  Dr.  Mori  have  determined  that 
diabetes mellitus is not a significant risk factor in 
the  development  of  RCC.  Research  has  shown  an 
increased risk of dying from RCC and a higher risk 
of death from RCC after excluding obese subjects 
without diabetes. Globally we can conclude that we 
need further prospective studies to evaluate the link 
between obesity and diabetes in the etiology of RCC 
because we don’t know if the association is true or 
confounded by obesity.
We  have  to  deal  with  a  similar  problem  with 
hypertension  and  its  treatment  as  Dr.  Washio  and 
Dr. Mori explain. Association between diuretic treatment 
and RCC has been showed in a few prospective studies. 
The problem is that they have been used as treatment 
for  hypertension,  so  it  is  difficult  to  separate  their 
effects from the effects of hypertension.6
In this Japanese population there is an association 
between hypertension and RCC incidence and also 
death with a relative risk of 4.27 and 1.98 respectively 
(95% confidence interval 2.07–8.79 and 1.06–3.70 
respectively).
Smoking has been related to an increased RCC risk 
for both sexes. For men a significant increase in risk 
was observed among past smokers (relative risk 1.51 
(1.08–2.11)) and current smokers (relative risk 2.30 
(1.55–3.41))  and  a  significant  dose-response  trend 
with pack-years of smoking has been noted. Men who 
had smoked more than 20 pack-years had 2.3 fold 
increased risk compared with non-smokers. Among 
women although the trend was not as strong as for 
men,  there  was  also  a  dose-response  relation  with 
pack-years detected.6
Despite these results which are based on western 
studies, in this Japanese population smokers showed 
a marginally increased risk of dying from RCC.
These  controversial  results  highlight  the  small 
statistical power of such studies which is a common 
limitation of epidemiological studies carried out in 
this disease because of small number of cases and 
deaths secondary to it.
I believe the main point to stress is diet, mainly 
because  of  the  differences  between  western  and 
Asian countries. These authors have concluded that 
a  Japanese  diet  with  starchy  roots  (such  as  taro, 
sweet potatoes and potatoes) was associated with a 
decreased risk of dying from RCC. However to the 
contrary there is no meaningful association with fruits 
and vegetables that have been advocated as protective 
factors in western countries.
Drinking of black tea, which is considered as a 
surrogate for westernized diet increases the risk of 
RCC deaths after adjustment of the other factors.
On reflection of these controversial results I have 
made  the  following  interpretations  regarding  the 
above mentioned risk factors.
There  has  been  much  discussion  about  the 
difficulties in reliably determining moderate effects, Cidon
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mainly when we are talking about behavioural risk 
factors that involve an element of choice such as diet 
or drinks or life-style habits.
Epidemiological  studies  could  be  useful  tools 
in  identifying  possible  health  hazards  providing 
sufficient reliability in differentiating between exposed 
and non-exposed subjects to these risk factors.
We must bear in mind that as Bretheau et al5 and 
others  have  published,  the  early  diagnosis  of  this 
disease significantly impacts on overall survival so 
they conclude that the patients with incidental tumors 
had a better prognosis than those with symptomatic 
tumors because of lower tumoral size and local stage. 
The most important conclusion we can obtain from 
their article is that the earlier the diagnosis of RCC, 
the better the prognosis for these patients.
It is in this context where it would be relevant to 
be able to stratify populations based on risk factors 
for RCC because this would allow establishment of 
strategies to prevent this disease which could have 
a  major  public  health  impact. The  most  important 
limitations to achieve this aim are the difficulties in 
considering not only the baseline exposures but to 
consider  changes  during  follow-up  too.  However 
we must not forget the exposure to many chemical 
agents or diet because these substances might not be 
effectively metabolized.13
The global differences mainly in results related with 
dietary habits need to be further explored in metabolic 
and laboratory investigations that may lead to clinical 
intervention studies and public health guidelines or 
recommendations. Epidemiology functions best when 
operating in a clinical environment with close access 
to laboratory studies.
Despite all these common limitations, Dr. Washio 
and Dr. Mori carried out a proper epidemiological 
study which allows us to better identify the risk factors 
of this rare malignancy in a different population as was 
performed with Japanese people, whose behavioral 
habits, mainly dietary habits, are different from our 
own.
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